Biotech’s Big Bets: AI, Gene Therapy, and New Drugs
Kilder
- STAT: Scientists link boy’s tumor to gene therapy viruses, in rare finding - statnews.com
- STAT: Gene therapy viruses linked to a boy’s tumor - statnews.com
- BioSpace: AI-fueled Isomorphic bags $2.1B, the second largest biotech round ever - BioSpace
- GEN: Gene Therapy ETX101 Improves Seizures and Neurodevelopment in Dravet Syndrome in Phase I/II - Genetic Engineering and Biotechnology News
- Cgtlive: ETX101 Gene Therapy Shows Early Developmental, Seizure Benefits in Dravet Syndrome - CGTLive®
- Firstwordpharma: Encoded's Dravet gene therapy holds up, but immune suppression may limit peak response - FirstWord Pharma
- Nature: At last, a pill that can prevent COVID after exposure to infected people - Nature
- Japantimes: Shionogi pill prevents COVID-19 in household exposure study - The Japan Times
- Bloomberg: Shionogi Pill Prevents Covid in Household Exposure Study - Bloomberg.com
- Fierce Biotech: With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’ - Fierce Biotech
- Bioworld: Beone’s BCL2 drug Beqalzi wins FDA nod in mantle cell lymphoma - BioWorld News
- Bioworld: Beone’s BCL2 drug Beqalzi wins FDA nod in mantle cell lymphoma - BioWorld News
- Fiercepharma: BeOne's Venclexta challenger Beqalzi nets FDA approval as first BCL-2 for mantle cell lymphoma - Fierce Pharma
- Seeking Alpha: BeOne wins FDA nod for Beqalzi in lymphoma (ONC:NASDAQ) - Seeking Alpha
- wikimedia: Photo by Bill Branson (Photographer) / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.